Order Now, Ships Today
One-time
| Quantity | Discount | Discounted price |
| 3 - 4 | 5% | $42.70 |
| 5 - 6 | 7% | $41.80 |
| 7 - 8 | 9% | $40.90 |
| 9 + | 11% | $40.01 |
These products are for laboratory research only and not intended for medical use. They are not FDA-approved to diagnose, treat, cure, or prevent any disease. By purchasing, you certify they will be used solely for research and not for human or animal consumption.
Hexarelin (also known as Examorelin) is a synthetic growth hormone–releasing peptide (GHRP) belonging to the GHS family. It functions as a ghrelin receptor (GHS-R1a) agonist, stimulating growth hormone secretion through both hypothalamic and pituitary signaling. Researchers have studied Hexarelin for its role in growth hormone modulation, tissue repair, and cardioprotective pathways in experimental models.
This research peptide is verified for 99%+ purity. COA: Hexarelin (5mg)
Products from Elite Miami Peptides do not include usage instructions, as they are strictly for in vitro research and prohibited by law for human or animal use. Misuse or unlawful application will result in permanent denial of service.
Each vial contains exactly what’s indicated on the label. For instance, a 10mg vial contains precisely 10mg of lyophilized peptide. Researchers may divide it into smaller research portions—such as four 2.5mg aliquots—but the total content remains the same.
Yes. All peptides are supplied in lyophilized powder form and do not come reconstituted. Any extra materials required for research, such as solvents or diluents, must be obtained separately.
When stored as a dry powder, peptides remain stable for up to 2 years.
Once reconstituted, the solution should be kept refrigerated and is typically stable for up to 2 months under proper storage conditions.
Hexarelin acts as a potent growth hormone secretagogue, stimulating both pituitary GH release and hypothalamic signaling pathways. In controlled studies, it has been shown to activate GH, IGF-1, and prolactin secretion, while also influencing lipid metabolism and muscle tissue repair. It is frequently studied alongside other GH analogs such as GHRP-2 and GHRP-6 to evaluate the comparative effects of peptide potency, receptor sensitivity, and systemic feedback responses.
Hexarelin is a strong GH-stimulating peptide. Research shows it can increase growth hormone, IGF-1, and prolactin, while also influencing fat use and muscle repair. Scientists compare it to similar peptides to study potency and how the body responds to different levels of GH signaling.
⚠️ Disclaimer: this product is not approved for medical use and is not intended to diagnose, treat, or prevent any disease. All information provided is for educational and research purposes only, and this product must never be used in humans or animals.
A synthetic GHRP (ghrelin receptor agonist) developed in the 1990s as part of the growth-hormone secretagogue class. Wikipedia
Sequence: His-D-2-Me-Trp-Ala-Trp-D-Phe-Lys-NH₂ Molecular Formula: C₄₇H₅₈N₁₂O₆ Molecular Weight: ~887.06 g/mol CAS: 140703-51-1. GenScript+1
Hexarelin has been studied extensively for its effects on GH release, tissue regeneration, and cardiovascular signaling. Key research areas include: Endocrine: GH, IGF-1, and pituitary axis stimulation. Metabolic: lipid utilization, glucose metabolism, and body composition models. Cellular: tissue regeneration and muscle recovery. Cardiovascular: studies exploring protective effects in myocardial tissue models. These findings make Hexarelin a valuable peptide for exploring GH-dependent growth and repair mechanisms in scientific environments.
In simple terms, Hexarelin is a lab-engineered peptide that helps researchers study how growth hormone is naturally produced and released in the body. It’s stronger and longer-lasting than many other GH peptides, making it a useful tool for understanding muscle recovery, energy balance, and tissue growth under experimental conditions. It’s important to note that Hexarelin is not approved for human or animal use — it is strictly for laboratory research.
Bowers C.Y., et al. (1999). Characterization of Hexarelin as a potent GH secretagogue in pituitary models. Locatelli V., et al. (2002). Comparative GH-releasing activity of Hexarelin versus GHRP-6. Broglio F., et al. (2001). Cardioprotective and endocrine properties of Hexarelin analogs. Muccioli G., et al. (2005). Hexarelin and ghrelin receptor interaction: mechanisms and downstream effects.
Sep 25, 2025
By far the best in the market! Good prices, transparent transaction no games! Most importantly extremely responsive! So if you’re looking for products that work this is your site!
Aug 20, 2025
The service and products from Elite Miami Peptides are amazing. I was turned on to the company by several of my peers and I ordered some peptides. Not only was the delivery fast, but I was also able to save money. I will be using Elite Miami Peptides again for ALL my peptide needs.
Sep 25, 2025
Great products, super fast shipping and so helpful. Always a great experience dealing with Elite Miami Peptides. I highly recommend EMP - these guys are great!
Aug 24, 2025
Gave me exactly what I wanted. The service and response was good. I have ordered from them before and will continue.
Our specialists respond within minutes to any order or product inquiry.
These products are for laboratory research only and not intended for medical use. They are not FDA-approved to diagnose, treat, cure, or prevent any disease. By purchasing, you certify they will be used solely for research and not for human or animal consumption.
By clicking the button above, you agree to receive marketing text messages from Elite Miami Peptides at the number provided. Consent is not a condition of purchase. Msg & data rates may apply. Reply STOP to cancel, HELP for help. View our Privacy Policy.
All compounds from Elite Miami Peptides are intended strictly for laboratory research purposes.
They are not for human use, consumption, or therapeutic applications.
Products are supplied exclusively to qualified professionals working in compliance with all applicable laws and regulations.
